Viewing Study NCT00675350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2026-02-22 @ 7:03 PM
Study NCT ID: NCT00675350
Status: COMPLETED
Last Update Posted: 2014-05-12
First Post: 2008-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors
Sponsor: ChemGenex Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Omacetaxine View
None Homoharringtonine View
None HHT View
None Solid and hematologic malignant tumors View